相关实验视频

Updated: Jun 9, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

合成,分子对接,ADMET研究和氨酸-化混合衍生物的抗菌活性

Zainab Ngaini¹, Mohamad Asri Jefferi, Saba Farooq¹

¹Faculty of Resource Science and Technology, Universiti Malaysia Sarawak, Kota Samarahan, Sarawak, Malaysia.

Natural product research

|October 30, 2024

概括

新的库马林-合金化合物对抗抗性细菌如Pseudomonas aeruginosa和大肠杆菌具有强大的抗菌活性,为药物开发提供了有希望的替代品.

科学领域:

药用化学医学化学
自然产品的合成自然产品的合成
抗微生物药物发现发现

背景情况:

抗菌素耐药性需要新的治疗药物.
自然衍生化合物为药物开发提供了丰富的来源.
库马林和石支架以其生物活动而闻名.

研究的目的:

为了合成和评估一系列基于天然产品的库马林石的抗菌性质.
研究这些新型化合物的结构-活性关系.
通过分子对接和ADMET研究来评估它们作为候选药物的潜力.

主要方法:

易于施特利希化,用于合成氨酸-化杂交物 (化合物4a-4i).
阿加尔井扩散方法用于确定针对Pseudomonas aeruginosa和Escherichia coli的抗菌抑制区.
分子对接模拟以预测结合亲和力.
ADMET (吸收,分布,新陈代谢,分泌,毒性) 的研究.

主要成果:

合成的库马林- (4a-4i) 显示出对P. aeruginosa (7-13毫米) 和大肠杆菌 (8-12毫米) 的显著抑制.
化合物4b和4g显示出最高的抑制区 (分别为13毫米和12毫米).
分子对接揭示了具有最高结合亲和力 (-10.1 kcal/mol) 的4b化合物.
ADMET研究表明,合成的化合物具有有利的类似药物的特性.

结论:

基于天然产品的库马林 - 石具有强大的抗菌活性,单独超过了安比西林和库马林.
混合结构,包括活性成分,有助于增强微生物抑制.
这些化合物代表了对抗抗菌素耐药性的进一步发展有前途的候选人.

关键词:

凝结凝结的情况埃斯特尔是一个埃斯特尔.相互作用不和基不和基自然产品是自然产品的产品.

更多相关视频

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...